Pfizer (PFE) 10-Q2017 Q1 Quarterly report

Filed: 11 May 17, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	8th grade Avg

New words: absence, advocate, affiliated, Alembic, Alpharma, Altergon, Amerigen, antirheumatic, Apotex, assurance, bad, begun, beneficiary, bidding, bill, Biochemique, bosutinib, Breckenridge, Bresch, Brexit, build, Cadila, callable, charitable, Citibank, clarify, closeout, clostridium, cohort, concentrated, concentration, Corrupt, cotransporter, criteria, death, Del, derecognition, difficile, displacement, disposition, document, dynamic, earliest, element, embedded, enantiomer, enrichment, enterprise, ertugliflozin, Esteve, Eucrisa, exceed, exhausted, explanation, fewer, filer, filtration, fine, Flector, free, freeze, gastric, glomerular, glucose, gradually, grand, harmonizing, Heather, House, Huahai, hypothetical, IBSA, inappropriate, indirect, Inline, inotuzumab, input, instance, instrument, Interactive, IPAB, Januvia, joined, jury, LEP, LIBOR, membership, Meridian, Merkel, metformin, mg, mild, missing, mitigated, modified, modify, MSN, multilateral, myeloid, neck, NHI, nonfinancial, nonrecurring, OECD, ointment, opposition, outflow, ozogamicin, passage, Patch, patchwork, Pensa, PF, Ph, precursor, Prinston, Prism, produce, produced, promissory, proportionately, pursuit, Racketeer, recall, recover, refractory, relapsed, replenish, responded, resubmission, retrospectively, scrutiny, seated, Secretary, Seiyaku, seizure, seller, Senate, sitagliptin, slightly, Solco, source, stabilize, subpoena, subtotal, Sun, suspension, Tadalafil, Taiwan, Teikoku, temporary, test, testing, therefrom, TKI, Torrent, transportation, trend, Tribunal, Trumenba, undiscounted, unjust, unlimited, UT, verdict, Viviant, write, wrongful, XBRL

Removed: accelerating, acquirer, adjunctive, admission, affirmed, aforementioned, Agila, aging, aid, allocate, ankylosing, anxiety, Argentina, atrial, autoimmune, avelumab, awarding, axial, bank, Baxter, Bextra, Biotech, blood, born, calicheamycin, cap, CentreSource, certifying, children, clarification, classified, Combine, commercialize, conjugate, content, correlation, corroborated, curtailment, curve, cytotoxic, dedicated, deduction, depressive, diligently, disorder, distribute, docket, DOJ, dosing, Dutch, DVT, dysfunction, elevated, embolism, engine, enjoined, entirety, epilepsy, erectile, ERISA, essentially, evenly, execution, exercisable, exercise, expert, fail, false, fibrillation, fibromyalgia, field, force, forma, forum, frequency, fulvestrant, function, generalized, Genotropin, GHD, Gibsonburg, GIP, Goldman, governing, hemophilia, hip, historical, hybrid, hypertension, imatinib, impaired, incurring, inflammatory, initially, injection, interested, intervene, intervening, intervention, introduced, juvenile, Kidney, knee, lifelong, lift, Lime, linked, marketplace, MDL, measuring, menopausal, menopause, merger, mesylate, misrepresenting, mRCC, mutual, neuroendocrine, neuropathic, nonradiographic, nonvalvular, noted, onset, pancreatic, pay, PCS, PE, permanently, plaque, polyarticular, polymorph, postmarketing, precise, predictability, preliminary, prepayment, preventing, pro, promotional, provisional, qui, quoted, Ratiopharm, RCC, realignment, realization, Rebif, recAP, recovery, recurrence, reinstated, reinstatement, released, Remsima, resumed, reversed, satisfied, Scandinavia, seal, SGA, show, smoking, spot, statutory, streamlining, stroke, submit, subsidy, substitute, successor, sum, surgery, susceptible, Switzerland, systemic, tam, tanezumab, testimony, Teva, thereof, thromboembolism, tigecycline, traded, Tygacil, uncertainty, undergone, Unobservable, unsealed, upholding, utilizing, vasomotor, vest, vested, VOC, whistleblower, wholesaler, wrongfully, yield

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

PFE similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

EXHIBIT 15

Accountants' Acknowledgment

To the Board of Directors and the Shareholders of Pfizer Inc.:

We hereby acknowledge our awareness of the use therein of our report dated May 11, 2017, included within the Quarterly Report on Form 10-Q of Pfizer Inc. for the quarter ended April 2, 2017 in the following Registration Statements:

-Form S-8 dated October 27, 1983 (File No. 2-87473),

-Form S-8 dated March 22, 1990 (File No. 33-34139),

-Form S-8 dated January 24, 1991 (File No. 33-38708),

-Form S-8 dated November 18, 1991 (File No. 33-44053),

-Form S-8 dated May 27, 1993 (File No. 33-49631),

-Form S-8 dated May 19, 1994 (File No. 33-53713),

-Form S-8 dated October 5, 1994 (File No. 33-55771),

-Form S-8 dated December 20, 1994 (File No. 33-56979),

-Form S-8 dated March 29, 1996 (File No. 333-02061),

-Form S-8 dated September 25, 1997 (File No. 333-36371),

-Form S-8 dated June 19, 2000 (File No. 333-39610),

-Form S-8 dated June 19, 2000 (File No. 333-39606),

-Form S-8 dated April 27, 2001 (File No. 333-59660),

-Form S-8 dated April 16, 2003 (File No. 333-104581),

-Form S-8 dated April 16, 2003 (File No. 333-104582),

-Form S-8 dated November 18, 2003 (File No. 333-110571),

-Form S-8 dated December 18, 2003 (File No. 333-111333),

-Form S-8 dated April 26, 2004 (File No. 333-114852),

-Form S-8 dated March 1, 2007 (File No. 333-140987),

-Form S-4 dated March 27, 2009 (File No. 333-158237),

-Form S-8 dated October 16, 2009 (File No. 333-162519),

-Form S-8 dated October 16, 2009 (File No. 333-162520),

-Form S-8 dated October 16, 2009 (File No. 333-162521),

-Form S-8 dated March 1, 2010 (File No. 333-165121),

-Form S-3ASR dated March 2, 2015 (File No. 333-202430),

-Form S-8 dated March 2, 2015 (File No. 333-202437), and

-Form S-4 dated September 3, 2015 (File No. 333-206758).

Pursuant to Rule 436 under the Securities Act of 1933 (the Act), such report is not considered a part of a registration statement prepared or certified by an independent registered public accounting firm, or a report prepared or certified by an independent registered public accounting firm within the meaning of Sections 7 and 11 of the Act.

/s/ KPMG LLP

New York, New York

May 11, 2017